Non-opioid Pain Patch Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)

The report covers Pain Patch Market Trends and the market is Segmented by Patch Type (Lidocaine Patches, Diclofenac Patches, Capsaicin Patches, Ketoprofen Patches, and Others), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Others), and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The market provides the value (in USD million) for the above-mentioned segments.

Non-opioid Pain Patch Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)

Non-opioid Pain Patch Industry Overview

The market is highly fragmented because numerous companies are working to help a large global population suffering from chronic pain. Various market players use different technologies to develop products that facilitate effective and prolonged drug release to increase consumer base and product penetration. Furthermore, the market is highly competitive, with fierce competition between existing players and new entrants. The global non-opioid pain patch market players are Endo Pharmaceuticals, Hisamitsu Pharmaceutical, Sanofi, Sorrento Therapeutics (SCILEX Pharmaceuticals), and TEH SENG Pharmaceutical Mfg. Co., Ltd, Teikoku Seiyaku Co. Ltd, Teva Pharmaceuticals, and Veridian Healthcare.

Non-opioid Pain Patch Market Leaders

  1. Endo Pharmaceuticals Inc.

  2. Hisamitsu Pharmaceutical Co. Inc.

  3. Teva Pharmaceuticals Industries Ltd.

  4. Veridian Healthcare

  5. Sanofi

  6. *Disclaimer: Major Players sorted in no particular order
Non-opioid Pain Patch Market Concentration